Cancer Outcomes in Washington, DC's Marginalized Populations
GrantID: 11204
Grant Funding Amount Low: $600,000
Deadline: January 10, 2023
Grant Amount High: $600,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Faith Based grants, Financial Assistance grants, Health & Medical grants, Higher Education grants, Housing grants, Municipalities grants.
Grant Overview
Target Outcomes for Early Cancer Assessment in Washington, DC
The Grants for Collaboration on Liquid Biopsy for Early Cancer Assessment program aims to support the development and validation of liquid biopsy technologies for early-cancer detection, risk assessment, and distinguishing cancer from benign disease. In Washington, DC, the priority outcomes for this grant are closely aligned with the District's healthcare goals and initiatives. The DC Department of Health, a key state agency, has emphasized the importance of early cancer detection in reducing health disparities and improving health outcomes for DC residents.
One of the primary target outcomes for this grant is the development of liquid biopsy technologies that can detect cancer at an early stage, when it is more treatable. This outcome is particularly relevant in Washington, DC, where there are significant disparities in cancer incidence and mortality rates among different racial and socioeconomic groups. For example, the cancer incidence rate in Ward 7 is 455.6 per 100,000 people, compared to 345.6 per 100,000 people in Ward 3. By developing more effective early detection technologies, grant recipients can help reduce these disparities and improve health outcomes for all DC residents.
Another key outcome for this grant is the validation of liquid biopsy technologies for risk assessment and distinguishing cancer from benign disease. This is an area where Washington, DC has a unique opportunity to leverage its strong research institutions and healthcare infrastructure. The District is home to several world-renowned research institutions, including the National Institutes of Health and the George Washington University Cancer Center. By supporting the development and validation of liquid biopsy technologies, the grant program can help accelerate the translation of research into clinical practice and improve cancer care in the District.
The geographic diversity of Washington, DC also presents opportunities for grant recipients to test and validate their technologies in different populations. For example, the District's urban and diverse population can provide valuable insights into the performance of liquid biopsy technologies in different racial and socioeconomic groups. Additionally, the District's proximity to Maryland and Virginia makes it an ideal location for collaborations and partnerships with neighboring jurisdictions.
Measuring Success in Washington, DC
To measure the success of the Grants for Collaboration on Liquid Biopsy for Early Cancer Assessment program in Washington, DC, the funder will be looking for outcomes such as the number of liquid biopsy technologies developed and validated, the number of cancer cases detected at an early stage, and the reduction in cancer disparities among different racial and socioeconomic groups. Grant recipients will be expected to track and report on these outcomes, as well as other metrics such as the sensitivity and specificity of their technologies.
Future Directions for Cancer Research in Washington, DC
The Grants for Collaboration on Liquid Biopsy for Early Cancer Assessment program is part of a broader effort to support cancer research and improve cancer care in Washington, DC. The District's strong research institutions, diverse population, and favorable business climate make it an attractive location for companies and researchers working on cancer diagnostics and treatments. By supporting the development and validation of liquid biopsy technologies, the grant program can help position Washington, DC as a leader in the field of cancer research and innovation.
Q: What are the key outcomes that the Grants for Collaboration on Liquid Biopsy for Early Cancer Assessment program is looking to achieve in Washington, DC? A: The program is looking to achieve outcomes such as the development and validation of liquid biopsy technologies for early-cancer detection, risk assessment, and distinguishing cancer from benign disease.
Q: How can grant recipients in Washington, DC leverage the District's healthcare infrastructure and research institutions to support their work? A: Grant recipients can leverage the District's strong research institutions, including the National Institutes of Health and the George Washington University Cancer Center, to support the development and validation of their liquid biopsy technologies.
Q: What is the significance of the DC Department of Health's emphasis on early cancer detection in reducing health disparities and improving health outcomes for DC residents? A: The DC Department of Health's emphasis on early cancer detection is significant because it highlights the need for effective early detection technologies, particularly in communities with high cancer incidence and mortality rates.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grants for Commercial-Scale Research on Sustainable Pest Management
This grant program aims to promote collaboration between researchers and extension professionals to...
TGP Grant ID:
71318
The Dance Progression Grant: Training and Career Development
This grant supports the training and development of talented individuals aspiring to launch professi...
TGP Grant ID:
72855
Empowerment Grants for Black/Brown Women Entrepreneurs
Applications are ongoing. These grants are more than just financial support; they represent a commit...
TGP Grant ID:
60179
Grants for Commercial-Scale Research on Sustainable Pest Management
Deadline :
Ongoing
Funding Amount:
$0
This grant program aims to promote collaboration between researchers and extension professionals to increase the adoption of sustainable pest manageme...
TGP Grant ID:
71318
The Dance Progression Grant: Training and Career Development
Deadline :
Ongoing
Funding Amount:
$0
This grant supports the training and development of talented individuals aspiring to launch professional careers in dance or pursue dance-related prof...
TGP Grant ID:
72855
Empowerment Grants for Black/Brown Women Entrepreneurs
Deadline :
Ongoing
Funding Amount:
$0
Applications are ongoing. These grants are more than just financial support; they represent a commitment to equality, diversity, and inclusion. By pro...
TGP Grant ID:
60179